Ensysce Biosciences Common Stock (ENSC) Live Share Price, Invest From India

Ensysce Biosciences Common Stock Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.26
Day's Price Range
$0.29
$0.27
3.70%
Downside
7.41%
Upside
52 Week's Low
52 Week's High
$0.23
52-Week Price Range
$2.75
$0.27
14.81%
Downside
918.52%
Upside

Ensysce Biosciences Common Stock share price movements today

Previous Close: $0.27
Open: $0.27
Volume: 1.8M
Day's Low - High: $0.26 - $0.29
52 Week Low - High: $0.23 - $2.75

Ensysce Biosciences Common Stock Historical Returns

1 Month Return: -8.44 %
3 Month Return: -52.82 %
1 Year Return: -87.26 %
3 Year Return: -99.24 %
5 Year Return: 0 %

Ensysce Biosciences Common Stock Stock Fundamentals & Key Indicators

Check Ensysce Biosciences Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1M

EPS (TTM)

-1.98

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-10.2M

Revenue (TTM)

4.7M

Profit Margin

-250.36%

Return On Equity TTM

-1149.11%

Ensysce Biosciences Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ensysce Biosciences Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Ensysce Biosciences Common Stock	BUY	$4.1M	NA	NA	-250.36%	NA
Alnylam Pharmaceuticals Common Stock	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex PharmaceuticalsCommon Stock	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Common Stock	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Ensysce Biosciences Common Stock Stock including INR - Dollar returns

The Ensysce Biosciences Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Ensysce Biosciences Common Stock investment value today

Current value as on today

₹13,834

Returns

-₹86,166

(-86.17%)

Returns from Ensysce Biosciences Common Stock Stock

-₹87,324 (-87.32%)

Dollar Impact

₹1,158 (+1.16%)

Analyst Recommendation on Ensysce Biosciences Common Stock Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Ensysce Biosciences Common Stock. Average target price of $16.45

Ensysce Biosciences Common Stock Share Price Target

Get share price movements and forecasts by analysts on Ensysce Biosciences Common Stock.

What analysts predicted

98.36%UPSIDE

Target Price

$16.45

Current Price

$0.27

Analyzed by

7 Analysts

Target

$16.45

Ensysce Biosciences Common Stock target price $16.45, a slight upside of 98.36% compared to current price of $0.27. According to 7 analysts rating.

Indian Investors' Interest in Ensysce Biosciences Common Stock Stock

Search interest for Ensysce Biosciences Common Stock Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:-59% versus previous 30 day period

Ensysce Biosciences Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	3	1	1	1	0	1	0
Gross Profit	-1	0	0	1	-2	1	0	-2	-	0
Operating Income	-3	-1	-1	0	-3	-1	-1	-3	-2	-3
EBITDA	-3	-1	-1	0	-3	-1	-1	0	-2	-3
Interest Expense	0	1	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	0
Income Before Tax	-3	-3	-1	0	-3	-1	-1	-3	-2	-3
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-3	-3	-1	0	-3	-1	-1	-3	-2	-3
Net Profit Margin	-680.23%	-1019.23%	-1082.41%	19.36%	-273.42%	-147.42%	-126.39%	-756.26%	-147.03%	-370.07%

Ensysce Biosciences Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	1	3	3	2	2	5	5
Gross Profit	-	-1	-3	3	3	-17	-5	-2	-
Operating Income	0	0	-3	-1	-19	-24	-10	-6	-10
EBITDA	0	0	-3	0	-19	-24	-10	-6	-10
Interest Expense	-	-	-	0	1	0	0	1	0
Depreciation	-	-	-	0	0	-	-	-	0
Income Before Tax	0	2	0	0	-29	-24	-10	-7	-10
Income Tax Expense	0	0	0	0	0	0	0	-	-
Net Income	0	2	1	0	-29	-24	-10	-7	-10
Net Profit Margin	0.00%	0.00%	83.70%	1.44%	-825.38%	-989.21%	-475.71%	-153.30%	-200.84%

Ensysce Biosciences Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-1	0	-3	-1	-1	-3	-5	-3
Operating Cash Flow	-3	-2	-1	0	-1	-2	-1	-1	-3
Investing Cash Flow	-	-	-	-	-	-	0	0	-
Financing Cash Flow	5	0	4	0	1	1	1	4	0
Change in Cash	2	-2	3	0	0	0	0	2	-3

Ensysce Biosciences Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	0	-29	-24	-10	-7	-10,176,187
Operating Cash Flow	-1	10	-1	-8	-17	-10	-7,502,700	-7,806,292
Investing Cash Flow	0	0	183	-	0	-	-	-123,643
Financing Cash Flow	0	-11	1	20	8	8	9,881,173	8,738,212
Change in Cash	0	0	0	12	-9	-2	2,378,473	808,277

Global Institutional Holdings in Ensysce Biosciences Common Stock

Funds	Holdings
Genworth Financial Wealth Mgmt Inc	0%
Williams & Novak LLC	0%
Perceptive Advisors LLC	0.59%
Jane Street Group LLC	0.09%
Morgan Stanley - Brokerage Accounts	0%

See all

Insights on Ensysce Biosciences Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ENSC stock has moved up by 8.0%
NO EFFECT
Against Peers
In the last 3 years, Ensysce Biosciences, Inc. Common Stock has experienced a drawdown of -99.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 77.1%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 106.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.88M → 960.99K (in $), with an average decrease of 49.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -2.76M → -3.55M (in $), with an average decrease of 28.5% per quarter

About Ensysce Biosciences Common Stock

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat opioid use disorder. Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.

Organisation	Ensysce Biosciences Common Stock
Headquarters	7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. D. Lynn Kirkpatrick Ph.D.
E-voting on shares	Click here to vote

Key Management of Ensysce Biosciences Common Stock

Name	Title
Dr. D. Lynn Kirkpatrick Ph.D.	President, CEO & Director
Mr. David C. Humphrey CPA	CFO, Secretary & Treasurer
Mr. Geoffrey Birkett	Chief Commercial Officer
Dr. Jeffrey Millard Ph.d.	Chief Operating Officer
Dr. William K. Schmidt Ph.D.	Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.	Chief Development Officer

FAQs

What is Ensysce Biosciences Common Stock share price today?

Ensysce Biosciences Common Stock share price today is $0.27 as on June 19, 2026 at 8:45 am IST at the close of the market. Ensysce Biosciences Common Stock share today touched a day high of $0.29 and a low of $0.26.

What is the 52 week high and 52 week low for Ensysce Biosciences Common Stock share?

Ensysce Biosciences Common Stock share touched a 52 week high of $2.75 on October 16, 2025 and a 52 week low of $0.23 on May 14, 2026. Ensysce Biosciences Common Stock stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $0.27,which is 90.18% down from its 52 week high and 17.39% up from its 52 week low.

What is Ensysce Biosciences Common Stock's market capitalisation today?

Ensysce Biosciences Common Stock market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Ensysce Biosciences Common Stock Stock (ENSC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ensysce Biosciences Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ensysce Biosciences Common Stock Shares that will get you 5.5556 shares as per Ensysce Biosciences Common Stock share price of $0.27 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Ensysce Biosciences Common Stock Stock (ENSC) from India?

Indian investors can start investing in Ensysce Biosciences Common Stock (ENSC) shares with as little as ₹94.323 or $1 (as of June 19, 2026 at 9:49 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Ensysce Biosciences Common Stock stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 9:49 am IST). Based on Ensysce Biosciences Common Stock share’s latest price of $0.27 as on June 19, 2026 at 8:45 am IST, you will get 37.0370 shares of Ensysce Biosciences Common Stock. Learn more about fractional shares .